Picard Medical, Inc.

Background

Company Name	Picard Medical, Inc.
Stock Symbol	PMI
Class Period	September 02, 2025 to October 31, 2025
Lead Plaintiff Motion Deadline	April 03, 2026

Submit Your Information

If you suffered a loss on your Picard Medical, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filling out this form mean you have joined any lawsuit.

First Name*

Middle Initial

Last Name*

Email*

Phone*

If representing a Corporation, Trust, Partnership or other entity, Name of Entity

If representing an Entity, Position at Entity

Mailing Address

City

State/Province

ZIP/Postal Code

Country

Are you a current or former employee of the company?

Did you purchase any shares before September 02, 2025?

Shares Purchased

Number of Shares	Buy Date	Price Per Share	Add
Purchased quantity	Purchased month Purchased day Purchased year

Shares Sold

Number of Shares	Sell Date	Price Per Share	Add
	Sold month Sold day Sold year

Additional Comments

Background

On October 23, 2025, during aftermarket trading hours, Picard’s stock crashed abruptly, plunging approximately 70%, from $13.20 to close at $3.99 per share.

Investigations and public reports have since indicated that Picard’s stock became the subject of an illicit social-media-based promotion scheme in which impersonators using stolen identities of real financial advisors touted Picard in online forums, chat groups, and social media posts in order to artificially inflate its price.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Picard was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; (3) that Picard’s public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price; and (4) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Submit Your Information